SEP 10, 2020 6:00 AM PDT

Pancreatic cancer patients see hope in this newly developed drug

A new drug developed by researchers at the University of Sheffield hopes to improve life expectancy and quality of life for patients with pancreatic cancer. The findings of the study, which show positive results from the drug in mice models, were published in the journal ACS Pharmacology & Translational Science.

Pancreatic cancer is particularly difficult to beat and only 7% of patients live to see five years post-diagnosis. This drug, which harnesses molecules called adrenomedullin-2 receptor antagonists, blocks the communication between the hormone called adrenomedullin and cancer cells. Adrenomedullin, while important for certain physiological functions, is dangerous because it stimulates the growth and metastasis of cancer.

Photo: Pixabay

"The most extraordinary part of this new therapy is the fact that nature designed the hormone adrenomedullin to have two different types of receptor - one which helps to regulate our blood pressure and the other which is involved in the way that cancer cells communicate with each other and the host cells, helping cancers to grow and spread," said Professor Tim Skerry from the University of Sheffield's Department of Oncology and Metabolism.  

By blocking this communication via the new drug, the researchers were able to demonstrate a positive effect in the treatment of pancreatic cancer in mouse models. "We have designed a unique piece to fit into nature's jigsaw which will block signals from one receptor but allow the other to work as normal. In blocking the hormone's communication with the cancer cells, we are cutting off its supply to the things that it needs to thrive. This means tumors can't grow as fast as they are starved of the resources they need and it becomes more difficult for them to spread to other areas of the body,” Skerry explained.

The team is currently on track to raise funding for first-in-human clinical trials. They say that the drug has implications not only for pancreatic cancer but also other hard-to-treat cancers like relapsed breast cancer and lung cancer

"Pancreatic cancer tumors are notoriously aggressive and difficult to treat and their location makes it easy for cancer to spread to nearby organs such as the liver and stomach. The nature of pancreatic cancers means it is hard to get current drugs into the tumor. We believe adrenomedullin-2 receptors offer advantages for pancreatic cancer patients,” says Skerry. "Over the past 30 years, the diagnosis and treatment of the vast majority of cancers have evolved rapidly, helping more people survive the disease than ever before. However, advances in treating pancreatic cancer and improving patient outcomes have had little effect on life expectancy. There are still cancers that are resistant to treatment and research is needed to solve those problems."

Sources: ACS Pharmacology & Translational Science, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 09, 2020
Genetics & Genomics
Using CRISPR to Destroy Cancer Cells
OCT 09, 2020
Using CRISPR to Destroy Cancer Cells
Researchers have developed a way to selectively target certain cancer cells with CRISPR.
OCT 14, 2020
Cancer
Research suggests statins could reduce the risk of cancer
OCT 14, 2020
Research suggests statins could reduce the risk of cancer
New research published in the journal eLife provides evidence that statins, the common cholesterol-lowering drugs, could ...
OCT 21, 2020
Cancer
Can Excess Fructose Cause Liver Cancer?
OCT 21, 2020
Can Excess Fructose Cause Liver Cancer?
Hepatocellular carcinoma, aka liver cancer, is an ever-increasing issue in the western world. While the lion’s sha ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
OCT 26, 2020
Chemistry & Physics
Fighting mesothelioma with gold nanotubes
OCT 26, 2020
Fighting mesothelioma with gold nanotubes
New research published in the journal Small details how gold nanotubes could be used to treat mesothelioma cancer. ...
Loading Comments...